--Worst 10 day stretch since the 10 days ending May 23, 2025, when it fell 9.17% --Down 46.25% from its all-time closing high of $113.45 on July 29, 2015 --Up 5.19% from 52 weeks ago (July 23, 2024), ...

Oakmark U.S. Large Value Strategy's return was 4.48% (net) for the reporting period vs. Russell 1000 Value Index that ...

A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2. Read more ...

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

The navigation of businesses increased sustainability with integrated conscious marketplace integration of Sustainable Development Goals in strategies of corporate marketing has emerged as the crucial ...

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some ...

Edward Ahn, CEO of MEDIPOST, Inc., reacts to the challenge of launching orphan drugs without complete evidence, particularly given their high cost and limited patient populations, and suggests ...

Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, leaving the drugmaker in a more vulnerable position when rival Eli ...

Shares of CVS Health Corp. CVS advanced 2.67% to $68.14 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.80% to 6,141.02 ...